Skip to main content
. 2021 Sep 27;12:737105. doi: 10.3389/fphar.2021.737105

TABLE 5.

Hazard ratios of cardiovascular disease for the top 10 frequently used polyherbal formulas in comparison with the matched non-CHM groups.

Polyherbal formulas Patients/total CHM users (%) Adjusted HR (95%CI)
Model 1 Model 2
Jia-Wei-Xiao-Yao-San 975/2,751 (35.4%) 0.87 (0.70–1.08) 0.91 (0.73–1.13)
Shao-Yao-Gan-Cao-Tang 636/2,751 (23.1%) 0.82 (0.63–1.05) 0.85 (0.66–1.10)
Ge-Gen-Tang 618/2,751 (22.5%) 0.77 (0.59–1.01) 0.80 (0.61–1.05)
Xiao-Chai-Hu-Tang 588/2,751 (21.4%) 0.79 (0.61–1.03) 0.82 (0.63–1.08)
Shu-Jing-Huo-Xue-Tang 585/2,751 (21.3%) 0.74 (0.57–0.96)* 0.76 (0.58–0.99)*
Zhi-Bo-Di-Huang-Wan 541/2,751 (19.7%) 0.83 (0.62–1.10) 0.89 (0.66–1.18)
Liu-Wei-Di-Huang-Wan 533/2,751 (19.4%) 0.79 (0.60–1.05) 0.83 (0.62–1.10)
Gan-Lu-Yin 529/2,751 (19.2%) 0.88 (0.67–1.16) 0.95 (0.72–1.25)
Ban-Xia-Xie-Xin-Tang 528/2,751 (19.2%) 0.80 (0.60–1.07) 0.80 (0.60–1.08)
Chuan-Qiong-Cha-Tiao-San 502/2,751 (18.3%) 0.74 (0.55–1.01) 0.78 (0.57–1.07)

Model 1: adjusted for age, gender, insured amount, and urbanization level.

Model 2: adjusted for age, gender, insured amount, urbanization level, comorbidities, and baseline drugs.

HR, hazard ratio; CHM, Chinese herbal medicine; CI, confidence interval.

*p-value < 0.05.